Contact
Please use this form to send email to PR contact of this press release:
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
TO:
Please use this form to send email to PR contact of this press release:
Ocugen Announces OCU400 Receives Orphan Drug Designations for Retinitis Pigmentosa and Leber Congenital Amaurosis
TO: